Transcend Therapeutics
Lily Eaker serves as a Senior Clinical Trial Associate at Transcend Therapeutics since April 2024. Previously, Lily held the role of Project Manager at Clario from November 2022 to April 2024, where responsibilities included overseeing global clinical trials and managing project timelines in compliance with regulatory standards. Prior experience includes working as a Clinical Research Coordinator at Mount Sinai Health System and a Research Assistant at both New York State Psychiatric Institute and Teachers College, Columbia University. Lily holds a Bachelor of Arts in Psychology from St. John's University and has experience in various research and clinical settings, emphasizing data management and compliance.
This person is not in any teams
This person is not in any offices
Transcend Therapeutics
1 followers
Transcend Therapeutics is a clinical-stage, neuroscience-focused company developing next-generation psychoactive medicines for neuropsychiatric disease. Transcend develops medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. We have real-world data showing that our lead product provided significant benefit to >85% of patients with PTSD and depression. We have already advanced our lead compound into an approved Phase II study in PTSD, with plans to expand into depression and other indications.